Replies to post #353964 on Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

LOL, so Elite is slowly capturing Adderall market share but they would INSTANTLY start making $100 million off those products...is that what I'm hearing?

Products which AREN'T even being sold currently? LOL

Let's review the tape of what I said:

The sad fact is that had Norco and Percocet been commercialized in a timely fashion, we very well could have $100 million in revenue by now.

Both Norco and Percocet were approved in 2018, more than 2.5 years ago. Those two drugs could have easily done $20M/year each. Add in the methadone and hydromorphone kicker, and "we very well could have $100 million in revenue by now." Of course, as your post rightly points out, Nasrat and team have come up lame in capturing Adderall market share, so shareholders are ultimately left to guess what kind of revenue return we might have received for the substantial dilution we suffered to develop all the drugs in the opioid bucket.